Sponsor Pipeline

Everest Medicines (China) Co.,Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-06 NCT05800873
Evaluate The Efficacy, Safety, Pharmacokinetics And Pharmacodynamics Of EVER001		 Trial completed
2026-08-06 NCT05800873
Evaluate The Efficacy, Safety, Pharmacokinetics And Pharmacodynamics Of EVER001		 date change Primary completion moved earlier: 2026-09-15 -> 2026-07-22
2026-08-06 NCT05800873
Evaluate The Efficacy, Safety, Pharmacokinetics And Pharmacodynamics Of EVER001		 date change Completion moved earlier: 2026-09-15 -> 2026-07-22
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07614477 Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of EVER001 in… Minimal Change Disease (MCD) Recruiting
Get alerts when Everest Medicines (China) Co.,Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free